Financhill
Back

Oncolytics Biotech Stock Predictions

Oncolytics Biotech Stock Forecast

  • Is Oncolytics Biotech Stock Undervalued?
    The current Oncolytics Biotech [ONCY] share price is $0.42. The Score for ONCY is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
  • ONCY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Oncolytics Biotech Stock Go Up Next Year?

Data Unavailable

Oncolytics Biotech Stock Rating

Data Unavailable

Oncolytics Biotech Stock Price History

Is ONCY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Canada
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
oncolyticsbiotech.com

52-Week Data

52-Week High:
1.53
52-Week Low:
0.37

Prediction Charts

Market Cap:
37.2M
Price in USD:
0.42
Volume:
7.1M
Beta:
1.71

Technical Analysis

SMA50:
0.55
SMA100:
0.66
SMA200:
0.83
52-Wk Change:
-60.53%

Stock Predictions

  • Is Oncolytics Biotech stock public?
    Yes, Oncolytics Biotech is a publicly traded company.
  • What is the Oncolytics Biotech stock quote today?
    The Oncolytics Biotech stock price is 0.42 USD today.
  • How to buy Oncolytics Biotech stock online?
    You can buy Oncolytics Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-7 0.52 0.52 0.55 0.51
May-8 0.51 0.54 0.54 0.51
May-9 0.52 0.52 0.53 0.51
May-12 0.54 0.54 0.54 0.51
May-13 0.53 0.53 0.54 0.52
May-14 0.52 0.52 0.54 0.51
May-15 0.50 0.50 0.53 0.50
May-16 0.49 0.47 0.50 0.45
May-19 0.47 0.44 0.50 0.42
May-20 0.44 0.43 0.45 0.41
May-21 0.42 0.42 0.44 0.41
May-22 0.42 0.40 0.45 0.40
May-23 0.40 0.42 0.44 0.37
May-27 0.42 0.40 0.42 0.39

Oncolytics Biotech Earnings

Data Unavailable

Oncolytics Biotech Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.07 per share, and a decrease next year of $0.02 per share.

* Oncolytics Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.